TCL Archive Bailes: ASCO To Strengthen State Affiliates, Begin Quality Of Care Study, Talk With FDA. May 26, 2000
TCL Archive In Senate testimony, NCI director uses survival rate as measure of progress for goal to “eliminate suffering and death due to cancer.” July 29, 2005
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
